Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Glial Cell Line Derived Neurotrophic Factor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Glial Cell Line Derived Neurotrophic Factormarket, defines the market attractiveness level of Glial Cell Line Derived Neurotrophic Factor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Glial Cell Line Derived Neurotrophic Factor industry, describes the types of Glial Cell Line Derived Neurotrophic Factor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glial Cell Line Derived Neurotrophic Factor market and the development prospects and opportunities of Glial Cell Line Derived Neurotrophic Factor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glial Cell Line Derived Neurotrophic Factor market in Chapter 13.
By Player:
GlaxoSmithKline Plc
Treeway BV
UniQure NV
By Type:
GSK-812
LAUR-301
TW-002
AMT-090
Others
By End-User:
Amyotrophic Lateral Sclerosis
Brain Ischemia
Parkinson's Disease
Retinal Degeneration
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Glial Cell Line Derived Neurotrophic Factor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Glial Cell Line Derived Neurotrophic Factor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Glial Cell Line Derived Neurotrophic Factor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Glial Cell Line Derived Neurotrophic Factor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Glial Cell Line Derived Neurotrophic Factor Market Analysis and Outlook to 2022
-
7.1 Global Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.2 United States Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.3 Europe Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.4 China Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.5 Japan Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.6 India Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
-
7.7 South Korea Glial Cell Line Derived Neurotrophic Factor Consumption (2017-2022)
8 Region and Country-wise Glial Cell Line Derived Neurotrophic Factor Market Analysis and Outlook to 2028
-
8.1 Global Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.2 United States Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.3 Europe Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.4 China Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.5 Japan Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.6 India Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
-
8.7 South Korea Glial Cell Line Derived Neurotrophic Factor Consumption Forecast (2022-2028)
9 Global Glial Cell Line Derived Neurotrophic Factor Market Outlook by Types and Applications to 2022
-
9.1 Global Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GSK-812 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LAUR-301 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TW-002 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global AMT-090 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Amyotrophic Lateral Sclerosis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Brain Ischemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Retinal Degeneration Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Glial Cell Line Derived Neurotrophic Factor Market Outlook by Types and Applications to 2028
-
10.1 Global Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GSK-812 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global LAUR-301 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TW-002 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global AMT-090 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Amyotrophic Lateral Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Brain Ischemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Retinal Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Glial Cell Line Derived Neurotrophic Factor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Glial Cell Line Derived Neurotrophic Factor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Glial Cell Line Derived Neurotrophic Factor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Glial Cell Line Derived Neurotrophic Factor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Glial Cell Line Derived Neurotrophic Factor Market Competitive Analysis
-
14.1 GlaxoSmithKline Plc
-
14.1.1 GlaxoSmithKline Plc Company Details
-
14.1.2 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Product and Service
-
14.2 Treeway BV
-
14.2.1 Treeway BV Company Details
-
14.2.2 Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Product and Service
-
14.3 UniQure NV
-
14.3.1 UniQure NV Company Details
-
14.3.2 UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Glial Cell Line Derived Neurotrophic Factor
-
Figure Glial Cell Line Derived Neurotrophic Factor Picture
-
Table Global Glial Cell Line Derived Neurotrophic Factor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glial Cell Line Derived Neurotrophic Factor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glial Cell Line Derived Neurotrophic Factor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Glial Cell Line Derived Neurotrophic Factor Consumption by Country (2017-2022)
-
Figure United States Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Table Europe Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Figure China Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Figure Japan Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Figure India Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Glial Cell Line Derived Neurotrophic Factor Consumption and Growth Rate (2017-2022)
-
Figure Global Glial Cell Line Derived Neurotrophic Factor Consumption Forecast by Country (2022-2028)
-
Figure United States Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Glial Cell Line Derived Neurotrophic Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GSK-812 Consumption and Growth Rate (2017-2022)
-
Figure Global LAUR-301 Consumption and Growth Rate (2017-2022)
-
Figure Global TW-002 Consumption and Growth Rate (2017-2022)
-
Figure Global AMT-090 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Amyotrophic Lateral Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Ischemia Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Degeneration Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global GSK-812 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LAUR-301 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TW-002 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AMT-090 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amyotrophic Lateral Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Ischemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retinal Degeneration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Glial Cell Line Derived Neurotrophic Factor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Glial Cell Line Derived Neurotrophic Factor Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Product and Service
-
Table Treeway BV (Foundation Year, Company Profile and etc.)
-
Table Treeway BV Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Treeway BV Glial Cell Line Derived Neurotrophic Factor Product and Service
-
Table UniQure NV (Foundation Year, Company Profile and etc.)
-
Table UniQure NV Glial Cell Line Derived Neurotrophic Factor Sales, Price, Value and Gross Profit (2017-2022)
-
Table UniQure NV Glial Cell Line Derived Neurotrophic Factor Product and Service
-
